Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

CATX holding history

Perspective Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CATX overviewAll 13F holders of CATXFull Q4 2025 holdings

Shares (Q4 2025)
3,490,658
Value
$9.60M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of CATX by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20253,490,658$9.60M<0.1%+52,793+1.5%AddedHolders
Q3 20253,437,865$11.8M<0.1%+163,532+5.0%AddedHolders
Q2 20253,274,333$11.3M<0.1%+207,282+6.8%AddedHolders
Q1 20253,067,051$6.53M<0.1%−77,816−2.5%ReducedHolders
Q4 20243,144,867$10.0M<0.1%+67,926+2.2%AddedHolders
Q3 20243,076,941$41.1M<0.1%+155,673+5.3%AddedHolders
Q2 20242,921,268$29.1M<0.1%−14,858,838−83.6%ReducedHolders
Q1 202417,780,106$21.2M<0.1%+4,566,356+34.6%AddedHolders
Q4 202313,213,750$5.31M<0.1%+395,124+3.1%AddedHolders
Q3 202312,818,626$3.51M<0.1%+99,189+0.8%AddedHolders
Q2 202312,719,437$8.50M<0.1%+719,985+6.0%AddedHolders
Q1 202311,999,452$7.66M<0.1%+5,948,654+98.3%AddedHolders
Q4 20226,050,798$1.50M<0.1%+2,9830.0%AddedHolders
Q3 20226,047,815$1.39M<0.1%00.0%UnchangedHolders
Q2 20226,047,815$1.87M<0.1%00.0%UnchangedHolders
Q1 20226,047,815$2.20M<0.1%−18,377−0.3%ReducedHolders
Q4 20216,066,192$2.35M<0.1%−54,317−0.9%ReducedHolders
Q3 20216,120,509$3.86M<0.1%00.0%UnchangedHolders
Q2 20216,120,509$4.88M<0.1%−87,873−1.4%ReducedHolders
Q1 20216,208,382$6.77M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.